AR002243A1 - Anticuerpos contra proteinas alogenicas y xenogenicas, su uso en diagnostico y terapia y metodos para la determinacion de los mismos. - Google Patents
Anticuerpos contra proteinas alogenicas y xenogenicas, su uso en diagnostico y terapia y metodos para la determinacion de los mismos.Info
- Publication number
- AR002243A1 AR002243A1 ARP950100034A AR10003495A AR002243A1 AR 002243 A1 AR002243 A1 AR 002243A1 AR P950100034 A ARP950100034 A AR P950100034A AR 10003495 A AR10003495 A AR 10003495A AR 002243 A1 AR002243 A1 AR 002243A1
- Authority
- AR
- Argentina
- Prior art keywords
- diagnosis
- therapy
- determination
- methods
- same
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/732—Antibody-dependent cellular cytotoxicity [ADCC]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Mycology (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a métodos de diagnóstico para la detección de anticuerpos naturales que reconocen proteínas extractables a partir deórganos de mamíferos que tienen pesos moleculares de aproximadamente 14 Kda dotados de actividad antitumoral cuando se los administra a especiesxenogénicas.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT94MI002238A IT1276860B1 (it) | 1994-11-04 | 1994-11-04 | Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR002243A1 true AR002243A1 (es) | 1998-03-11 |
Family
ID=11369803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP950100034A AR002243A1 (es) | 1994-11-04 | 1995-11-02 | Anticuerpos contra proteinas alogenicas y xenogenicas, su uso en diagnostico y terapia y metodos para la determinacion de los mismos. |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP0789716B1 (es) |
| JP (1) | JPH10508591A (es) |
| KR (1) | KR100426029B1 (es) |
| CN (1) | CN1046737C (es) |
| AR (1) | AR002243A1 (es) |
| AT (1) | ATE192166T1 (es) |
| AU (1) | AU690756B2 (es) |
| BR (1) | BR9509556A (es) |
| CA (1) | CA2204380A1 (es) |
| CZ (1) | CZ288322B6 (es) |
| DE (1) | DE69516534T2 (es) |
| DK (1) | DK0789716T3 (es) |
| ES (1) | ES2147617T3 (es) |
| FI (1) | FI971879A (es) |
| GR (1) | GR3033956T3 (es) |
| HU (1) | HUT76880A (es) |
| IL (1) | IL115862A (es) |
| IT (1) | IT1276860B1 (es) |
| NO (1) | NO972046L (es) |
| NZ (1) | NZ295171A (es) |
| PL (1) | PL181115B1 (es) |
| PT (1) | PT789716E (es) |
| RU (1) | RU2160445C2 (es) |
| TR (1) | TR199501353A2 (es) |
| WO (1) | WO1996014340A1 (es) |
| ZA (1) | ZA959255B (es) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283634B1 (it) * | 1996-05-10 | 1998-04-23 | Zetesis Spa | Un metodo citofluorimetrico per la determinazione nel siero di anti- corpi anti-antigene tumorali |
| US20010014471A1 (en) * | 1999-04-15 | 2001-08-16 | Vytautas Naktinis | Recombinant protein and its use in therapy and diagnostics |
| IT201600127428A1 (it) * | 2016-12-16 | 2018-06-16 | Cusani Alberto Bartorelli | Nuova proteina ricombinante uk 114 in forma stabile polimerica per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne |
| IT201900022203A1 (it) * | 2019-11-26 | 2021-05-26 | Cusani Alberto Bartorelli | Proteine uk 114 da salmone per uso nella terapia, nella diagnostica e nella prevenzione di neoplasie maligne |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1244879B (it) * | 1990-12-11 | 1994-09-12 | Alberto Bartorelli | Estratti da tessuti animali, utili in terapia e in diagnostica. |
-
1994
- 1994-11-04 IT IT94MI002238A patent/IT1276860B1/it active IP Right Grant
-
1995
- 1995-10-30 BR BR9509556A patent/BR9509556A/pt not_active Application Discontinuation
- 1995-10-30 DE DE69516534T patent/DE69516534T2/de not_active Expired - Fee Related
- 1995-10-30 CA CA002204380A patent/CA2204380A1/en not_active Abandoned
- 1995-10-30 PL PL95319878A patent/PL181115B1/pl not_active IP Right Cessation
- 1995-10-30 AU AU38453/95A patent/AU690756B2/en not_active Ceased
- 1995-10-30 EP EP95936566A patent/EP0789716B1/en not_active Expired - Lifetime
- 1995-10-30 HU HU9701505A patent/HUT76880A/hu unknown
- 1995-10-30 CZ CZ19971314A patent/CZ288322B6/cs not_active IP Right Cessation
- 1995-10-30 AT AT95936566T patent/ATE192166T1/de not_active IP Right Cessation
- 1995-10-30 JP JP8515018A patent/JPH10508591A/ja not_active Ceased
- 1995-10-30 RU RU97108978/14A patent/RU2160445C2/ru not_active IP Right Cessation
- 1995-10-30 PT PT95936566T patent/PT789716E/pt unknown
- 1995-10-30 NZ NZ295171A patent/NZ295171A/en unknown
- 1995-10-30 DK DK95936566T patent/DK0789716T3/da active
- 1995-10-30 KR KR1019970702940A patent/KR100426029B1/ko not_active IP Right Cessation
- 1995-10-30 CN CN95195990A patent/CN1046737C/zh not_active Expired - Fee Related
- 1995-10-30 ES ES95936566T patent/ES2147617T3/es not_active Expired - Lifetime
- 1995-10-30 WO PCT/EP1995/004239 patent/WO1996014340A1/en active IP Right Grant
- 1995-11-02 TR TR95/01353A patent/TR199501353A2/xx unknown
- 1995-11-02 IL IL11586295A patent/IL115862A/en active IP Right Grant
- 1995-11-02 ZA ZA959255A patent/ZA959255B/xx unknown
- 1995-11-02 AR ARP950100034A patent/AR002243A1/es unknown
-
1997
- 1997-05-02 FI FI971879A patent/FI971879A/fi unknown
- 1997-05-02 NO NO972046A patent/NO972046L/no not_active Application Discontinuation
-
2000
- 2000-07-14 GR GR20000401641T patent/GR3033956T3/el not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE368054T1 (de) | Verbindungen und methoden zur modulierung von occludin-abhängiger gewebepermeabilität | |
| DE60006100D1 (de) | Lang wirkende insulinotrope peptide | |
| PT1132097E (pt) | Ancoras celulares e de proteinas sericas e conjugados | |
| TR199801179T2 (xx) | Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri. | |
| TR200003161T2 (tr) | Poliol-IFN-Beta konjugatları | |
| ATE211467T1 (de) | 4-amino-derivate der mycophenolsäure mit immun suppressiver wirkung | |
| ATE210127T1 (de) | 6-substituierte mycophenolsäurederivate mit immun suppressiver wirkung | |
| NZ288883A (en) | Conjugates comprising coagulation factors | |
| CY1111863T1 (el) | Αντισωματα εναντιον υποδοχεα θανατου 4 (dr4) και χρησεις αυτων | |
| ATE353363T1 (de) | Immunstimulierende zusammensetzung und verfahren | |
| MY120109A (en) | Disposable body fluid absorbent garment | |
| ATE375362T1 (de) | Von cyclophilin b abstammende tumorantigen- peptide | |
| PT749317E (pt) | Aplicacoes terapeuticas de produtos dimericos de proteinas bactericidas indutoras da permeabilidade | |
| DE60028965D1 (de) | Materialen zur vermehrung von weichgewebe und deren herstellungs- und verwendungsmethoden | |
| NO971341L (no) | Promoter for reseptor tyrosinkinase TIE | |
| DK0754229T3 (da) | Afamin: et humant serum albumin-lignende protein | |
| ATE421319T1 (de) | Mit s-nitrosothiol angereicherte erythrocyten und deren verwendung | |
| TR199902775T2 (xx) | 20(S)-Kamptotesin glikokonjugeleri. | |
| AR002243A1 (es) | Anticuerpos contra proteinas alogenicas y xenogenicas, su uso en diagnostico y terapia y metodos para la determinacion de los mismos. | |
| CA2070647A1 (en) | Use of an anticoagulant as a diagnostic agent | |
| TR199801732T2 (xx) | Yeni taksoitler, bunlar�n haz�rlanmalar� ve ila� bile�imleri. | |
| PT768886E (pt) | Efeitos de revestimento endotelial e tratamento de desordens vasospasticas | |
| CA2184175A1 (en) | Isolated, tyrosinase derived peptides and uses thereof | |
| DE69928523D1 (de) | Verotoxin b untereinheit zur immunisierunug | |
| ATE210126T1 (de) | 4-amino-6-substituierte mycophenolsäurederivate mit immunsuppressiver wirkung |